HUC3-637
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HUC3-637, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]